Drug Shortage Report for MINT-QUETIAPINE
Report ID | 46030 |
Drug Identification Number | 02438003 |
Brand name | MINT-QUETIAPINE |
Common or Proper name | Quetiapine |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 count bottles |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-04-16 |
Estimated end date | 2018-05-31 |
Actual end date | 2018-05-08 |
Shortage status | Resolved |
Updated date | 2018-05-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-05-09 | English | Compare |
v5 | 2018-05-08 | French | Compare |
v4 | 2018-05-08 | English | Compare |
v3 | 2018-04-17 | English | Compare |
v2 | 2018-04-16 | French | Compare |
v1 | 2018-04-16 | English | Compare |
Showing 1 to 6 of 6